Overview of DENV associated Cell line (Mutation)

ID Literature Title Group
1 39230303 Envelope domain III E(324), E(351), and E(380) mutations lever adaptive evolution of DENV-1 genotype I
Mutation
2 26135599 An Epitope-Substituted DNA Vaccine Improves Safety and Immunogenicity against Dengue Virus Type 2
Mutation
3 37112626 Recombinant Modified Vaccinia Virus Ankara Expressing a Glycosylation Mutant of Dengue Virus NS1 Induces Specific Antibody and T-Cell Responses in Mice
Mutation
4 35397074 Non-structural protein 1 (NS1) variants from dengue virus clinical samples revealed mutations that influence NS1 production and secretion
Mutation
5 39599894 Single-Nucleus and Spatial Transcriptomics Revealing Host Response Differences Triggered by Mutated Virus in Severe Dengue
Mutation
6 22771779 Resistance analysis of an antibody that selectively inhibits dengue virus serotype-1
Mutation
7 40339178 A novel immunogen comprising a bc loop and mutant fusion loop epitopes generates potent neutralization and protective abilities against flaviviruses without risk of disease enhancement
Mutation
8 34735113 In Vitro and In Vivo Stability of P884T, a Mutation that Relocalizes Dengue Virus 2 Non-structural Protein 5
Mutation
9 23124109 Crucial role of the N-glycans on the viral E-envelope glycoprotein in DC-SIGN-mediated dengue virus infection
Mutation
10 21669186 Role of CD137 signaling in dengue virus-mediated apoptosis
Mutation
11 24959738 Dengue type four viruses with E-Glu345Lys adaptive mutation from MRC-5 cells induce low viremia but elicit potent neutralizing antibodies in rhesus monkeys
Mutation
12 24466115 Recombinant production of the amino terminal cytoplasmic region of dengue virus non-structural protein 4A for structural studies
Mutation
13 20975939 In vitro and in vivo studies identify important features of dengue virus pr-E protein interactions
Mutation
14 24348242 The type-specific neutralizing antibody response elicited by a dengue vaccine candidate is focused on two amino acids of the envelope protein
Mutation
15 37555662 Dengue virus serotypic replacement of NS3 protease or helicase domain causes chimeric viral attenuation but can be recovered by a compensated mutation at helicase domain or NS2B, respectively
Mutation
16 27181378 Novel antiviral activity of bromocriptine against dengue virus replication
Mutation
17 38301907 Mutation of conserved histidine residues of dengue virus envelope protein impairs viral like particle maturation and secretion
Mutation
18 32402284 A Non-structural 1 Protein G53D Substitution Attenuates a Clinically Tested Live Dengue Vaccine
Mutation
19 33160000 Identification of quinolone derivatives as effective anti-Dengue virus agents
Mutation
20 29758236 Identification of Compound-B, a novel anti-dengue virus agent targeting the non-structural protein 4A
Mutation
21 28740124 Evaluation of Sofosbuvir (beta-D-2'-deoxy-2'-alpha-fluoro-2'-beta-C-methyluridine) as an inhibitor of Dengue virus replication
Mutation
22 31654671 A novel flavivirus entry inhibitor, BP34610, discovered through high-throughput screening with dengue reporter viruses
Mutation
23 26694200 Characterization of in vitro dengue virus resistance to carrageenan
Mutation
24 37243188 Identification of Key Residues in Dengue Virus NS1 Protein That Are Essential for Its Secretion
Mutation
25 29294313 K48-linked polyubiquitination of dengue virus NS1 protein inhibits its interaction with the viral partner NS4B
Mutation
26 29037976 Characterization of a dengue NS4B inhibitor originating from an HCV small molecule library
Mutation
27 28235683 Insights into the coordinated interplay of the sHP hairpin and its co-existing and mutually-exclusive dengue virus terminal RNA elements for viral replication
Mutation
28 39384752 Genomic surveillance reveals a dengue 2 virus epidemic lineage with a marked decrease in sensitivity to Mosnodenvir
Mutation
29 37661255 Dengue virus 3 genotype I (GI) lineage 1 (L1) isolates elicit differential cytopathic effect with syncytium formation in human glioblastoma cells (U251)
Mutation
30 35817240 Generation of soluble, cleaved, well-ordered, native-like dimers of dengue virus 4 envelope protein ectodomain (sE) suitable for vaccine immunogen design
Mutation
31 37378517 Identification of an Arylnaphthalene Lignan Derivative as an Inhibitor against Dengue Virus Serotypes 1 to 4 (DENV-1 to -4) Using a Newly Developed DENV-3 Infectious Clone and Replicon
Mutation
32 27716465 Evasion of early innate immune response by 2'-O-methylation of dengue genomic RNA
Mutation
33 28456663 Comparative whole genome analysis of dengue virus serotype-2 strains differing in trans-endothelial cell leakage induction in vitro
Mutation
34 38096749 Preexisting inter-serotype immunity drives antigenic evolution of dengue virus serotype 2
Mutation
35 34372598 Potential Phosphorylation of Viral Nonstructural Protein 1 in Dengue Virus Infection
Mutation
36 26197333 Amino Terminal Region of Dengue Virus NS4A Cytosolic Domain Binds to Highly Curved Liposomes
Mutation
37 30707666 Mutagenesis of the dengue virus NS4A protein reveals a novel cytosolic N-terminal domain responsible for virus-induced cytopathic effects and intramolecular interactions within the N-terminus of NS4A
Mutation
38 35865937 Impact of Intrahost NS5 Nucleotide Variations on Dengue Virus Replication
Mutation
Contents
Description
Disease Group Note
  • The label in Group indicates that the disease is mentioned in mutation or integration research. Click the eye label to view the corresponding module information.